US Stock MarketDetailed Quotes

Aura Biosciences (AURA)

Watchlist
  • 7.010
  • -0.040-0.57%
Close May 1 16:00 ET
  • 7.010
  • 0.0000.00%
Post 16:10 ET
450.04MMarket Cap-3.98P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aura Biosciences (AURA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.19%-84.74M
14.54%-20.47M
-31.89%-20.14M
-28.81%-20.77M
4.49%-23.36M
-24.99%-79.81M
-37.76%-23.95M
0.84%-15.27M
-10.13%-16.13M
-48.99%-24.45M
Net income from continuing operations
-22.17%-106.19M
1.06%-25.56M
-24.18%-26.13M
-32.86%-27.02M
-39.47%-27.48M
-13.76%-86.92M
-16.73%-25.83M
-13.67%-21.04M
-11.14%-20.34M
-12.82%-19.71M
Depreciation and amortization
-7.69%1.13M
-6.53%272K
-10.54%280K
-8.63%286K
-4.90%291K
-5.56%1.22M
-10.19%291K
-8.75%313K
4.33%313K
-6.71%306K
Other non cash items
7.35%1.58M
10.14%402K
-1.26%392K
6.39%383K
15.23%401K
-19.98%1.47M
-48.88%365K
-12.56%397K
6.51%360K
5.14%348K
Change In working capital
326.00%5.97M
265.39%1.56M
-41.89%1.96M
17.51%2.03M
106.22%423K
-159.49%-2.64M
-146.31%-942K
318.07%3.38M
-18.36%1.73M
-1,223.54%-6.8M
-Change in prepaid assets
203.25%4.03M
731.29%2.68M
-66.02%-1.53M
-110.13%-121K
180.08%3M
-209.08%-3.9M
-181.73%-425K
-4.88%-924K
-27.49%1.2M
-263.61%-3.75M
-Change in payables and accrued expense
59.54%3.29M
-289.08%-554K
3.03%3.95M
230.24%2.67M
3.45%-2.77M
-9.30%2.06M
-85.13%293K
99.53%3.83M
5.35%807K
-20.32%-2.87M
-Change in other current assets
622.22%47K
60.81%-194K
-121.85%-92K
-2,155.56%-185K
825.00%518K
89.53%-9K
-381.25%-495K
2,706.67%421K
111.69%9K
128.00%56K
-Change in other current liabilities
-76.65%-1.39M
-19.68%-377K
-816.00%-358K
-16.08%-332K
-37.13%-325K
40.39%-788K
50.24%-315K
120.33%50K
-27.68%-286K
-8.22%-237K
Cash from discontinued investing activities
Operating cash flow
-6.19%-84.74M
14.54%-20.47M
-31.89%-20.14M
-28.81%-20.77M
4.49%-23.36M
-24.99%-79.81M
-37.76%-23.95M
0.84%-15.27M
-10.13%-16.13M
-48.99%-24.45M
Investing cash flow
Cash flow from continuing investing activities
-48.28%35.6M
0.43%29.82M
-545.13%-44.02M
0.69%19.98M
217.29%29.81M
160.39%68.82M
132.95%29.7M
-54.28%9.89M
-7.32%19.84M
114.05%9.4M
Net PPE purchase and sale
64.33%-447K
41.14%-176K
86.80%-45K
92.57%-39K
-112.50%-187K
-76.73%-1.25M
5.68%-299K
-278.89%-341K
-172.02%-525K
19.27%-88K
Net investment purchase and sale
-48.57%36.04M
0.02%30M
-529.85%-43.97M
-1.72%20.02M
216.32%30M
161.87%70.07M
133.40%29.99M
-52.90%10.23M
-5.71%20.37M
114.20%9.48M
Cash from discontinued investing activities
Investing cash flow
-48.28%35.6M
0.43%29.82M
-545.13%-44.02M
0.69%19.98M
217.29%29.81M
160.39%68.82M
132.95%29.7M
-54.28%9.89M
-7.32%19.84M
114.05%9.4M
Financing cash flow
Cash flow from continuing financing activities
4,737.30%77.16M
409.58%2.77M
509.36%4.36M
84,151.81%69.93M
-62.06%96K
-98.36%1.6M
-99.42%543K
-55.97%716K
-96.65%83K
25.87%253K
Net common stock issuance
--52.57M
--2.77M
--3.29M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
1,441.32%24.58M
--0
50.28%1.08M
28,107.23%23.41M
-62.06%96K
6.05%1.6M
47.15%543K
161.31%716K
-87.42%83K
25.87%253K
Cash from discontinued financing activities
Financing cash flow
4,737.30%77.16M
409.58%2.77M
509.36%4.36M
84,151.81%69.93M
-62.06%96K
-98.36%1.6M
-99.42%543K
-55.97%716K
-96.65%83K
25.87%253K
Net cash flow
Beginning cash position
-22.43%32.46M
84.61%48.32M
250.60%108.14M
44.17%38.99M
-22.43%32.46M
-65.80%41.85M
-53.57%26.18M
-36.43%30.84M
-31.14%27.05M
-65.80%41.85M
Current changes in cash
398.31%28.01M
92.84%12.12M
-1,181.06%-59.8M
1,721.18%69.13M
144.27%6.55M
88.34%-9.39M
143.29%6.29M
-159.45%-4.67M
-58.92%3.8M
82.18%-14.8M
Effect of exchange rate changes
---186K
---160K
---14K
--9K
---21K
--0
--0
--0
--0
--0
End cash Position
85.71%60.28M
85.71%60.28M
84.61%48.32M
250.60%108.14M
44.17%38.99M
-22.43%32.46M
-22.43%32.46M
-53.57%26.18M
-36.43%30.84M
-31.14%27.05M
Free cash flow
-5.10%-85.19M
14.87%-20.65M
-29.30%-20.19M
-24.98%-20.81M
4.07%-23.54M
-25.56%-81.06M
-36.98%-24.25M
-0.78%-15.61M
-12.23%-16.65M
-48.54%-24.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.19%-84.74M14.54%-20.47M-31.89%-20.14M-28.81%-20.77M4.49%-23.36M-24.99%-79.81M-37.76%-23.95M0.84%-15.27M-10.13%-16.13M-48.99%-24.45M
Net income from continuing operations -22.17%-106.19M1.06%-25.56M-24.18%-26.13M-32.86%-27.02M-39.47%-27.48M-13.76%-86.92M-16.73%-25.83M-13.67%-21.04M-11.14%-20.34M-12.82%-19.71M
Depreciation and amortization -7.69%1.13M-6.53%272K-10.54%280K-8.63%286K-4.90%291K-5.56%1.22M-10.19%291K-8.75%313K4.33%313K-6.71%306K
Other non cash items 7.35%1.58M10.14%402K-1.26%392K6.39%383K15.23%401K-19.98%1.47M-48.88%365K-12.56%397K6.51%360K5.14%348K
Change In working capital 326.00%5.97M265.39%1.56M-41.89%1.96M17.51%2.03M106.22%423K-159.49%-2.64M-146.31%-942K318.07%3.38M-18.36%1.73M-1,223.54%-6.8M
-Change in prepaid assets 203.25%4.03M731.29%2.68M-66.02%-1.53M-110.13%-121K180.08%3M-209.08%-3.9M-181.73%-425K-4.88%-924K-27.49%1.2M-263.61%-3.75M
-Change in payables and accrued expense 59.54%3.29M-289.08%-554K3.03%3.95M230.24%2.67M3.45%-2.77M-9.30%2.06M-85.13%293K99.53%3.83M5.35%807K-20.32%-2.87M
-Change in other current assets 622.22%47K60.81%-194K-121.85%-92K-2,155.56%-185K825.00%518K89.53%-9K-381.25%-495K2,706.67%421K111.69%9K128.00%56K
-Change in other current liabilities -76.65%-1.39M-19.68%-377K-816.00%-358K-16.08%-332K-37.13%-325K40.39%-788K50.24%-315K120.33%50K-27.68%-286K-8.22%-237K
Cash from discontinued investing activities
Operating cash flow -6.19%-84.74M14.54%-20.47M-31.89%-20.14M-28.81%-20.77M4.49%-23.36M-24.99%-79.81M-37.76%-23.95M0.84%-15.27M-10.13%-16.13M-48.99%-24.45M
Investing cash flow
Cash flow from continuing investing activities -48.28%35.6M0.43%29.82M-545.13%-44.02M0.69%19.98M217.29%29.81M160.39%68.82M132.95%29.7M-54.28%9.89M-7.32%19.84M114.05%9.4M
Net PPE purchase and sale 64.33%-447K41.14%-176K86.80%-45K92.57%-39K-112.50%-187K-76.73%-1.25M5.68%-299K-278.89%-341K-172.02%-525K19.27%-88K
Net investment purchase and sale -48.57%36.04M0.02%30M-529.85%-43.97M-1.72%20.02M216.32%30M161.87%70.07M133.40%29.99M-52.90%10.23M-5.71%20.37M114.20%9.48M
Cash from discontinued investing activities
Investing cash flow -48.28%35.6M0.43%29.82M-545.13%-44.02M0.69%19.98M217.29%29.81M160.39%68.82M132.95%29.7M-54.28%9.89M-7.32%19.84M114.05%9.4M
Financing cash flow
Cash flow from continuing financing activities 4,737.30%77.16M409.58%2.77M509.36%4.36M84,151.81%69.93M-62.06%96K-98.36%1.6M-99.42%543K-55.97%716K-96.65%83K25.87%253K
Net common stock issuance --52.57M--2.77M--3.29M----------0--0--0--------
Proceeds from stock option exercised by employees 1,441.32%24.58M--050.28%1.08M28,107.23%23.41M-62.06%96K6.05%1.6M47.15%543K161.31%716K-87.42%83K25.87%253K
Cash from discontinued financing activities
Financing cash flow 4,737.30%77.16M409.58%2.77M509.36%4.36M84,151.81%69.93M-62.06%96K-98.36%1.6M-99.42%543K-55.97%716K-96.65%83K25.87%253K
Net cash flow
Beginning cash position -22.43%32.46M84.61%48.32M250.60%108.14M44.17%38.99M-22.43%32.46M-65.80%41.85M-53.57%26.18M-36.43%30.84M-31.14%27.05M-65.80%41.85M
Current changes in cash 398.31%28.01M92.84%12.12M-1,181.06%-59.8M1,721.18%69.13M144.27%6.55M88.34%-9.39M143.29%6.29M-159.45%-4.67M-58.92%3.8M82.18%-14.8M
Effect of exchange rate changes ---186K---160K---14K--9K---21K--0--0--0--0--0
End cash Position 85.71%60.28M85.71%60.28M84.61%48.32M250.60%108.14M44.17%38.99M-22.43%32.46M-22.43%32.46M-53.57%26.18M-36.43%30.84M-31.14%27.05M
Free cash flow -5.10%-85.19M14.87%-20.65M-29.30%-20.19M-24.98%-20.81M4.07%-23.54M-25.56%-81.06M-36.98%-24.25M-0.78%-15.61M-12.23%-16.65M-48.54%-24.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -